BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24332268)

  • 1. Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy.
    Damodaran O; van Heerden J; Nowak AK; Bynevelt M; McDonald K; Marsh J; Lee G
    J Clin Neurosci; 2014 Mar; 21(3):478-81. PubMed ID: 24332268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
    Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
    J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and survival of patients harboring histological variants of glioblastoma.
    Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
    J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
    Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
    J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliosarcoma. A study of 13 tumors, including p53 and CD34 immunohistochemistry.
    Sreenan JJ; Prayson RA
    Arch Pathol Lab Med; 1997 Feb; 121(2):129-33. PubMed ID: 9126039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary gliosarcoma: the clinicopathological features and the development of a patient-derived xenograft model of gliosarcoma.
    Kiang KM; Chan AA; Leung GK
    BMC Cancer; 2021 Mar; 21(1):265. PubMed ID: 33706745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
    Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
    J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cerebral gliosarcoma: clinico-pathologic study of 8 cases].
    Ayadi L; Charfi S; Khabir A; Kalle R; Sellami A; Makni S; Boudawara Z; Sellami-Boudawara T
    Tunis Med; 2010 Mar; 88(3):142-6. PubMed ID: 20415184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary gliosarcoma--clinical experience from a regional cancer centre in north India.
    Biswas A; Kumar N; Kumar P; Vasishta RK; Gupta K; Sharma SC; Patel F; Mathuriya SN
    Br J Neurosurg; 2011 Dec; 25(6):723-9. PubMed ID: 21591852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary gliosarcoma with extra-cranial metastases: a report and review of the literature.
    Dawar R; Fabiano AJ; Qiu J; Khushalani NI
    Clin Neurol Neurosurg; 2013 Apr; 115(4):375-80. PubMed ID: 22795300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients.
    Han SJ; Yang I; Ahn BJ; Otero JJ; Tihan T; McDermott MW; Berger MS; Prados MD; Parsa AT
    Cancer; 2010 Mar; 116(5):1358-66. PubMed ID: 20052717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gliosarcoma: a clinical and radiological analysis of 48 cases.
    Yi X; Cao H; Tang H; Gong G; Hu Z; Liao W; Sun L; Chen BT; Li X
    Eur Radiol; 2019 Jan; 29(1):429-438. PubMed ID: 29948068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gliosarcomas: analysis of 11 cases do two subtypes exist?
    Salvati M; Caroli E; Raco A; Giangaspero F; Delfini R; Ferrante L
    J Neurooncol; 2005 Aug; 74(1):59-63. PubMed ID: 16078109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gliosarcoma: a clinical study.
    Lutterbach J; Guttenberger R; Pagenstecher A
    Radiother Oncol; 2001 Oct; 61(1):57-64. PubMed ID: 11578729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative epidemiology of gliosarcoma and glioblastoma and the impact of Race on overall survival: A systematic literature review.
    Gerges C; Elder T; Penuela M; Rossetti N; Maynard M; Jeong S; Wright CH; Wright J; Zhou X; Burant C; Sajatovic M; Hodges T
    Clin Neurol Neurosurg; 2020 Aug; 195():106054. PubMed ID: 32650210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of clinico-pathological parameters and O⁶-methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcoma.
    Singh G; Mallick S; Sharma V; Joshi N; Purkait S; Jha P; Sharma MC; Suri V; Julka PK; Mahapatra AK; Singh M; Kale SS; Sarkar C
    Neuropathology; 2012 Oct; 32(5):534-42. PubMed ID: 22380407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gliosarcoma: The Distinct Genomic Alterations Identified by Comprehensive Analysis of Copy Number Variations.
    Cheng CD; Chen C; Wang L; Dong YF; Yang Y; Chen YN; Niu WX; Wang WC; Liu QS; Niu CS
    Anal Cell Pathol (Amst); 2022; 2022():2376288. PubMed ID: 35757013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.
    Cachia D; Kamiya-Matsuoka C; Mandel JJ; Olar A; Cykowski MD; Armstrong TS; Fuller GN; Gilbert MR; De Groot JF
    J Neurooncol; 2015 Nov; 125(2):401-10. PubMed ID: 26354773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic features of primary and postirradiation cerebral gliosarcoma.
    Perry JR; Ang LC; Bilbao JM; Muller PJ
    Cancer; 1995 Jun; 75(12):2910-8. PubMed ID: 7773942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.
    Smith DR; Wu CC; Saadatmand HJ; Isaacson SR; Cheng SK; Sisti MB; Bruce JN; Sheth SA; Lassman AB; Iwamoto FM; Wang SH; Canoll P; McKhann GM; Wang TJC
    J Neurooncol; 2018 Apr; 137(2):303-311. PubMed ID: 29264835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.